Clinical Efficacy of Multi-Focal Low-Intensity Extracorporeal Shockwave Therapy in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Prospective-Randomized, Double Blind, Placebo-Controlled Study
Purpose: To assess the safety and effect of the multifocal low-intensity extracorporeal shockwave therapy (MESWT) in the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Materials and Methods: We randomly separated 30 patients with CP/CPPS into a MESWT and placebo group of...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Society for Sexual Medicine and Andrology
2022-10-01
|
| Series: | The World Journal of Men's Health |
| Subjects: |
| Summary: | Purpose: To assess the safety and effect of the multifocal low-intensity extracorporeal shockwave therapy (MESWT) in the
treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
Materials and Methods: We randomly separated 30 patients with CP/CPPS into a MESWT and placebo group of same number
using prospective-randomized, double-blind design. The participants’ National Institutes of Health Chronic Prostatitis
Symptom Index (NIH-CPSI) total and subdomain scores, International Prostate Symptom Score (IPSS), International Index of
Erectile Function-5 (IIEF-5), and visual analogue scale (VAS) were assessed and compared at baseline and at finishing immediately
and 4 weeks after procedure and also were compared between MESWT and placebo group.
Results: A total of 30 participants were randomized a MESWT or placebo group. Twenty of thirty participants completed this
trial. NIH-CPSI total and subdomain scores, IPSS, IIEF-5, and VAS had significantly ameliorated compared with baseline in
the MESWT group at 4 weeks assessment. Furthermore, comparison of the results from MESWT and placebo groups represented
statistically significant differences in NIH-CPSI total and subdomain scores, IPSS, IIEF-5, and VAS. No side effects or
events were occurred in both groups of the participants during study periods.
Conclusions: MESWT can be an effective treatment modality in patients with CP/CPPS as it improves pain and QoL. |
|---|---|
| ISSN: | 2287-4208 2287-4690 |